Binding Site’s Immunologicals Group is pleased to announce the addition of eight new recombinant antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research
The new assay runs on the company’s LIAISON® MDX qPCR system, a scalable benchtop instrument that delivers qualitative and quantitative, sample-to-answer, multi-analyte results
In the study, children whose mothers took 800 or more micrograms of folic acid (the amount in most prenatal vitamins) had a significantly lower risk of developing autism spectrum disorder
It is unclear whether registered outcomes accurately reflect the trial protocol and whether registration improves the reporting of primary outcomes in publication